Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer.
Thaiparambil J, Dong J, Grimm SL, Perera D, Ambati CSR, Putluri V, Robertson MJ, Patel TD, Mistretta B, Gunaratne PH, Kim MP, Yustein JT, Putluri N, Coarfa C, El-Zein R.
Thaiparambil J, et al. Among authors: coarfa c.
Cancer Med. 2023 Jan;12(1):584-596. doi: 10.1002/cam4.4933. Epub 2022 Jun 8.
Cancer Med. 2023.
PMID: 35676822
Free PMC article.